Please login to the form below

Not currently logged in
Email:
Password:

hypereosinophilic syndrome

This page shows the latest hypereosinophilic syndrome news and features for those working in and with pharma, biotech and healthcare.

Nucala works in rare inflammatory disease, says GSK

Nucala works in rare inflammatory disease, says GSK

GlaxoSmithKline is eyeing another regulatory filing for its IL-5 inhibitor Nucala, after reporting positive phase 3 results with the drug in rare disease hypereosinophilic syndrome (HES).

Latest news

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
The Difference Collective

Welcome to the Difference Collective – a healthcare communications team of 80+ talented experts who Deliver Differently. We’re purpose-built around...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....